posicor
filmsko obložena tableta - mibefradil
rozor 10 mg/10 mg filmsko obložene tablete
mylan healthcare d.o.o. - ezetimib; rosuvastatin - filmsko obložena tableta - ezetimib 10 mg / 1 tableta rosuvastatin10 mg / 1 tableta; rosuvastatin 10 mg / 1 tableta - rosuvastatin in ezetimib
rozor 10 mg/10 mg filmsko obložene tablete
ezetimib; rosuvastatin - filmsko obložena tableta - ezetimib 10 mg / 1 tableta rosuvastatin10 mg / 1 tableta; rosuvastatin 10 mg / 1 tableta - rosuvastatin in ezetimib
rozor 20 mg/10 mg filmsko obložene tablete
ezetimib; rosuvastatin - filmsko obložena tableta - ezetimib 10 mg / 1 tableta rosuvastatin20 mg / 1 tableta; rosuvastatin 20 mg / 1 tableta - rosuvastatin in ezetimib
ezetimib/simvastatin actavis 10 mg/10 mg tablete
actavis group ptc ehf. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta simvastatin10 mg / 1 tableta; simvastatin 10 mg / 1 tableta - simvastatin in ezetimib
ezetimib/simvastatin actavis 10 mg/20 mg tablete
actavis group ptc ehf. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta simvastatin20 mg / 1 tableta; simvastatin 20 mg / 1 tableta - simvastatin in ezetimib
bosulif
pfizer europe ma eeig - bosutinib (kot monohidrat) - leukemija, myeloid - antineoplastic agents, protein kinase inhibitors - bosulif je indiciran za zdravljenje odraslih bolnikov z:novo diagnozo kronična faza (cp) philadelphia kromosom-pozitivno kronične myelogenous levkemijo (ph+ cml). cp, pospešeni fazi (ap), in pišu faza (bp) ph+ cml predhodno zdravljenih z eno ali več tirozin kinaza serotonina(s) [tki(s)] in za koga imatinib, nilotinib in dasatinib ki se ne štejejo za ustrezne možnosti zdravljenja.
jakavi
novartis europharm limited - ruksolitinib (kot fosfat) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastična sredstva - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi je indiciran za zdravljenje odraslih bolnikov z polycythaemia vera, ki so odporne ali nestrpne hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.
m-m-rvaxpro
merck sharp & dohme b.v. - ošpice virus enders' edmonston sev (v živo, zmanjšan), mumpsu virus jeryl lynn (raven b) sev (v živo, zmanjšan), virus rdečk wistar ra 27/3 sev (v živo, zmanjšan) - rubella; mumps; immunization; measles - cepiva - m-m-rvaxpro je označen za sočasno cepljenje proti ošpicam, mumpsu in rdečkam pri posameznikov 12 mesecev ali več. za uporabo v ošpice izbruhov, ali za post-izpostavljenost cepljenje, ali za uporabo v prej necepljenih otrocih, starejših od 12 mesecev, ki so v stiku z dovzetni nosečnice in osebe verjetno, da je dovzetna za mumpsu in rdečkam.
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunosupresivi - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).